Welcome to another episode of Delta, where we delve into the cutting-edge innovations in healthcare and health tech. In this episode, we sit down with Chris Green, the Chief Business Officer of Endiatx, to discuss their groundbreaking work in addressing gastric cancer through PillBot.

Join us as we explore the incredible journey of Endiatx over the past nine months, including their achievements in human trials in New Zealand and their strategic relationships with clinical advisors like Dr. Kumabri from the Mayo Clinic. Discover the future vision of Endiatx and how their innovative PillBot technology aims to revolutionize cancer screening and improve patient outcomes globally.

Chris also shares valuable fundraising advice for medical device startups, the importance of building rapport during pitches, and insights into the challenges an ...